OR-AIRSHIP
Customer engagement company Airship today announced that it is launching a free version of Apptimize’s Feature Flags solution, enabling app developers to control the scope and timing of feature launches in order to validate success and reduce risk prior to full rollout. From new apps to those with massive audiences, developers can use Feature Flags by signing up for a free account , or take advantage of newly reduced pricing for unlimited Feature Flags from Apptimize.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200715005238/en/
The challenge with updating mobile apps is amplified by lengthy approval cycles required by the App Store and Google Play, which means new features either need to wait for the next update cycle or leverage suboptimal web views that lead to disjointed customer experiences. Apptimize Feature Flags allow companies like Quizlet, Stash and Western Union to maintain multiple branches of code within apps to gradually release new features to a small subset of users first — quickly rolling features back if needed, or fully deploying them as they are proven successful. This level of fine-grained control is vital in the competitive app environment, and is even more so now as businesses innovate with mobile to create new growth opportunities and revenue streams.
“To ensure the millions of students who use Quizlet’s learning app have the optimal experience and can study effectively, we run A/B testing on all new features before they are fully released which means a smooth process is essential to our success,” states Allen Pan, mobile engineer at Quizlet. “Apptimize is our go-to for A/B testing because its tools provide easy-to-use controls to test and validate different configurations, including their feature flags for rollouts, and the results are easy to read and integrate into our internal analytics platform.”
Whether it's new curbside pickup experiences, appointment booking processes, or implementing enhanced recommendations or social selling features, developers can use Apptimize Feature Flags to choose when and to whom new features are accessible, and easily turn them on or off. For example:
- VIP Customers: provide exclusive or first-access to a brand’s gold loyalty members
- By Location: different regions may have different expectations, requiring gradual rollout to 40 percent of users in Germany but only 10 percent of users in France as an example
- By Demographics: from high-value customers to gender, developers can set Feature Flags to control rollout to specific groups
- By Behavioral Segments: use custom groups to target feature rollout to users with different affinities, interests, or behaviors
According to a senior software engineer at The Western Union Company, “Before Apptimize, we couldn't control the rollout of features to specific markets, which was especially challenging as we manage multiple apps across the globe and had to wait for each of their app release cycles. Now we can ramp up, roll back or even schedule feature releases to launch across various countries and user segments, and with Apptimize's support have developed a common framework for our different apps to control feature releases and experimentation across multiple user segments.”
For more inspiration, download Airship’s “5 Ways to Use Feature Flags to Supercharge Your Mobile Growth,” or read a complimentary copy of Forrester Research, Inc.’s “The Life-Changing Magic Of Simplifying Your Mobile App,” April 23, 2020.
“Exceptional mobile-first experiences are more important than ever as companies strive to offer customers new levels of ease-of-use, convenience, and innovation that win their hearts and wallets,” said Brett Caine, CEO and president, Airship. “However, there are far too many businesses that maintain a ‘best guess’ and ‘fingers-crossed’ mentality that risks precious development resources, creates suboptimal user experiences, and jeopardizes hard-fought, expensive user acquisition efforts. We’ve now made it even easier — and free — for businesses to adopt feature release management and start reaping the rewards that optimization unlocks.”
In addition to feature release management, the Enterprise version of Apptimize offers unlimited multivariate testing. Marketers can launch experiments in minutes through its Visual Editor without coding or app updates, while developers can leverage programmatic testing for more complex experimentation with one-time configuration of dynamic variables that can be changed instantly to add new variants. These testing capabilities allow for the highest ROI when launching new features.
About Apptimize
Apptimize, an Airship company, is the most used multivariate testing and feature release management solution for mobile apps, also covering websites and OTT. Hundreds of leading global brands have gained advantage over competitors by creating amazing mobile experiences with Apptimize.
Now, together with Airship, marketers and product owners can now unify digital engagement and digital experimentation to optimize the entire customer journey end-to-end — from driving more testing participation to creating consistent and optimized experiences as customers move across messaging channels and digital properties.
Learn more about Apptimize by visiting its website , reading its blog or following it on Twitter or LinkedIn .
About Airship
Marketing and digital experience teams at thousands of the world’s most admired companies rely on Airship’s Customer Engagement Platform to create deeper connections with customers by delivering incredibly relevant, coordinated messages across channels.
Founded in 2009 as a pioneer in push notifications, Airship now gives brands the user-level data, engagement channels, AI orchestration and services they need to deliver push notifications, emails, SMS, in-app messages, mobile wallet cards and more to exactly the right person in exactly the right moment — building trust, boosting engagement, driving action and growing value.
Learn more about our Customer Engagement Platform , read our blog or follow us on Twitter , LinkedIn and Facebook .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200715005238/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press release
Based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only medicine to significantly improve overall survival versus chemotherapy in this patient population If approved, DATROWAY could become the standard of care in this setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Produc
Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press release
SteQeyma™45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will facilitate subcutaneous administration in patients with plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD)1The new autoinjector option increases convenience, enhances individual patient experience and expands administration options Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution f
Megaport Expands into India, Accelerating Global Growth with Extreme IX Acquisition18.12.2025 02:15:00 CET | Press release
Through the Extreme Exchange (IX) acquisition, Megaport gains seven Internet Exchanges and access to 40+ data centres across India’s fastest-growing digital hubs. Megaport Limited (ASX: MP1) (“Megaport”), the world’s leading Network as a Service (NaaS) provider, today announced the acquisition of Extreme IX,India’s leading Internet Exchange operator, from Extreme Labs, a Bulgaria-headquartered software and network engineering company that incubated the Extreme IX platform. The acquisition expands Megaport’s global platform into one of the world’s fastest-growing digital infrastructure markets and supports the Company’s strategy to deliver scalable, high-performance connectivity services across APAC. The acquisition establishes Megaport’s presence across seven Internet Exchanges in major Indian metros: Delhi, Kolkata, Hyderabad, Chennai, Bengaluru, Mumbai, and Pune, connecting 40+ data centres and more than 400 customers. It also accelerates Megaport’s planned market entry by nearly thr
IonQ and QuantumBasel Expand Long-Term Partnership in Next-Generation Quantum Systems17.12.2025 22:10:00 CET | Press release
Extension solidifies QuantumBasel as IonQ’s Innovation Center in Europe; adds IonQ Tempo and next-generation system to advance quantum commercialization IonQ (NYSE: IONQ), the world’s leading quantum company, today announced an expanded agreement with QuantumBasel, the quantum initiative of uptownBasel, Switzerland’s innovation campus. The extended contract grants QuantumBasel ownership of its existing IonQ Forte Enterprise system and secures ownership of a next-generation Tempo system. This new agreement brings the total deal value of the QuantumBasel and IonQ partnership to over $60 million and extends IonQ’s on-site presence in Switzerland four more years, continuing through 2029. QuantumBasel is IonQ’s official Innovation Center in Europe, serving as a hub for European industry, academia, and research institutions to explore practical quantum computing applications and access IonQ’s latest enterprise-grade systems. “Our extended partnership with QuantumBasel represents a cornerston
Suzano Starts Up New Production Line, Boosting Its Fluff Pulp Capacity by 400%17.12.2025 21:50:00 CET | Press release
A R$490 million investment expands the supply of raw material used in the production of absorbent items Suzano, the world’s largest pulp producer, has commenced operations this week at its new fluff pulp production line located in its Limeira unit in Brazil’s São Paulo state. This R$490 million investment increases Suzano’s total fluff pulp production capacity by more than 400%, from 100,000 to 440,000 tonnes per year. The project involved converting the existing pulp line at the Limeira unit into a flexible machine, capable of producing both Eucafluff® and market pulp. Eucafluff® is used in the production of absorbent and personal hygiene products, such as baby and adult diapers, sanitary pads and pet pads. Then market pulp is supplied for making products including toilet paper, printing and writing papers, and paper packaging. Launched in 2015, Eucafluff® is the world’s first fluff pulp made from eucalyptus, delivering unique advantages like enhanced softness and flexibility, which t
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
